Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis

Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology

(2020) Andreas Kerschbaumer et al.   NATURE MEDICINE

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

(2020) Andrea Rubbert-Roth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis

(2018) Georgia Salanti et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial

(2018) Mark C Genovese et al.   LANCET

Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect

(2018) Vincent Germain et al.   ANNALS OF THE RHEUMATIC DISEASES

Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance

(2017) Marc Scherlinger et al.   JOINT BONE SPINE

New concepts of clinical trials in rheumatoid arthritis

(2016) Robert Landewé et al.   CURRENT OPINION IN RHEUMATOLOGY

The Emergence of the Randomized, Controlled Trial

(2016) Laura E. Bothwell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Review of head-to-head study designs in rheumatoid arthritis

(2016) Fleischmann R. et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials?

(2010) Mark Sinyor et al.   JOURNAL OF CLINICAL PSYCHIATRY

Design Makes a Difference: A Meta-Analysis of Antidepressant Response Rates in Placebo-Controlled Versus Comparator Trials in Late-Life Depression

(2007) Joel R. Sneed et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY